• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Coly-Mycin M Parenteral Solution (colistimethate sodium, USP)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

March 2013

Summary View

WARNINGS

  • Maximum daily dose calculated from colistin base activity should not exceed 5 mg/kg/day with normal renal function.